Miller Investment Trust’s Miller Convertible Total Return ETF had total net Assets of $14017578.70 ($14.0 million) as of 2026-07-31, with Uber Technologies at 3.781413190852%. The portfolio report also identifies BridgeBio Pharma, Liberty Media, Alphabet and Snowflake among its largest holdings, showing investors the fund’s principal disclosed positions.

Key Highlights

  • Omnicell represented 2.53% of the portfolio, with its holding valued at $354,788.92.
  • BridgeBio Pharma’s position was valued at $489,385.74 and represented 3.49% of net assets.
  • The BBH sweep vehicle held $106,836.31, equal to 0.76% of the portfolio.

Miller Investment Trust’s Miller Convertible Total Return ETF had total net assets of $14,017,578.7 ($14.0 million) as of 31 July 2026. The portfolio also included positions carrying DBT CORP, EP CORP and STIV classifications.

$14M Portfolio Snapshot

Total assets were $14,028,434.55, while liabilities were $10,855.85, resulting in the reported net assets of $14,017,578.7. The BBH sweep vehicle held $106,836.31 and represented 0.76% of the portfolio.

Holdings Beyond The Leaders

Omnicell (NASDAQ: OMCL) had a position valued at $354,788.92, equal to 2.53% of the portfolio. DoorDash (NASDAQ: DASH) represented 2.52%, with its holding valued at $352,934.19. Burlington Stores accounted for 2.28% and was valued at $319,346.14. Cogent Biosciences (NASDAQ: COGT) represented 2.21%, with a holding valued at $309,245.09. Itron accounted for 2.2% and was valued at $307,809.7. LivaNova (NASDAQ: LIVN) represented 2.14%, with its holding valued at $300,273.59. Snowflake’s position represented 2.7% and was valued at $378,563.18, while Revolution Medicines (NASDAQ: RVMD) represented 3.27% and was valued at $458,869.15. Halozyme Therapeutics accounted for 3.03% of the portfolio, with a holding valued at $424,533.73. TransMedics (NASDAQ: TMDX) represented 2.87% and was valued at $402,709.05. These positions were listed alongside the fund’s other long holdings.